Harvest Portfolios Group Inc. Has $55.49 Million Holdings in Agilent Technologies, Inc. $A

Harvest Portfolios Group Inc. lowered its stake in Agilent Technologies, Inc. (NYSE:A) by 17.2% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 407,816 shares of the medical research company’s stock after selling 84,809 shares during the quarter. Harvest Portfolios Group Inc.’s holdings in Agilent Technologies were worth $55,492,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Bridgefront Capital LLC acquired a new stake in shares of Agilent Technologies in the third quarter worth about $1,323,000. Wellington Management Group LLP lifted its position in shares of Agilent Technologies by 4.8% in the third quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock worth $1,203,990,000 after buying an additional 433,342 shares during the last quarter. Envestnet Asset Management Inc. lifted its position in shares of Agilent Technologies by 3.8% in the third quarter. Envestnet Asset Management Inc. now owns 607,914 shares of the medical research company’s stock worth $78,026,000 after buying an additional 22,498 shares during the last quarter. Generation Investment Management LLP lifted its position in shares of Agilent Technologies by 10.1% in the third quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock worth $816,043,000 after buying an additional 582,093 shares during the last quarter. Finally, Champlain Investment Partners LLC lifted its position in shares of Agilent Technologies by 33.3% in the third quarter. Champlain Investment Partners LLC now owns 895,770 shares of the medical research company’s stock worth $114,972,000 after buying an additional 223,750 shares during the last quarter.

Agilent Technologies Trading Down 1.5%

Agilent Technologies stock opened at $110.43 on Wednesday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. The business’s 50-day simple moving average is $114.85 and its 200-day simple moving average is $130.10. The firm has a market capitalization of $31.21 billion, a PE ratio of 24.38, a PEG ratio of 2.36 and a beta of 1.22. Agilent Technologies, Inc. has a 52 week low of $107.07 and a 52 week high of $160.27.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The business had revenue of $1.80 billion during the quarter, compared to the consensus estimate of $1.81 billion. During the same quarter in the previous year, the firm posted $1.31 earnings per share. The company’s revenue for the quarter was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Equities research analysts forecast that Agilent Technologies, Inc. will post 5.95 earnings per share for the current year.

Wall Street Analyst Weigh In

A has been the subject of a number of analyst reports. Wells Fargo & Company reduced their price target on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a research report on Thursday, February 26th. Morgan Stanley dropped their price objective on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 3rd. Barclays dropped their price objective on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. TD Cowen dropped their price objective on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Finally, HSBC assumed coverage on Agilent Technologies in a research note on Tuesday, January 20th. They issued a “buy” rating and a $180.00 price objective on the stock. Two research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, Agilent Technologies currently has a consensus rating of “Buy” and a consensus target price of $163.71.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.